232 related articles for article (PubMed ID: 6295693)
1. [Effects of suloctidil therapy on platelet function in patients with on obliterating arteriopathy of the lower limbs].
Davì G; Pinto A; Novo S; Avellone G; Galati D; Mazzola A
Clin Ter; 1982 Oct; 103(2):131-7. PubMed ID: 6295693
[No Abstract] [Full Text] [Related]
2. [Medium term treatment with suloctidil in obliterating arteriopathies of the lower limbs. Personal experience].
Marongiu G; Dettori G; Gadeddu A; Noya G; Angius P; Biglioli P
Minerva Cardioangiol; 1983; 31(7-8):407-10. PubMed ID: 6316206
[No Abstract] [Full Text] [Related]
3. [Behavior and significance of beta-thromboglobulin in chronic obliterating arteriopathy of the lower limbs. Preliminary research].
Binaghi F; Valle E; Manconi E; Pitzus F
Cardiologia; 1982 Nov; 27(11):1043-9. PubMed ID: 6085827
[No Abstract] [Full Text] [Related]
4. [Medical therapy of chronic obstructive arteriopathy of the lower extremities. A controlled clinical study of suloctidil versus xanthinol].
Spinella G; Majorana M
Clin Ter; 1983 Mar; 104(5):375-81. PubMed ID: 6303677
[No Abstract] [Full Text] [Related]
5. Clinical and biological activity of the antiplatelet agent suloctidil in treatment of idiopathic recurrent vein thrombosis (I.R.V.T.).
Moriau M; Col-De Beys C; Pardonge E; Ferrant A
Thromb Haemost; 1982 Feb; 47(1):27-31. PubMed ID: 6280332
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the platelet component in chronic obliterating vascular disease of the lower limbs].
Avellone G; Nova S; Gullotti D; Mandalà V
Boll Soc Ital Cardiol; 1979; 24(2):135-41. PubMed ID: 548089
[No Abstract] [Full Text] [Related]
7. [Hemorrheological survey in a group with arteriosclerotic vascular disease treated with suloctidil].
Caimi G; Catania A; Frazzetta F; Capobianco D; Francavilla G; Romano A; Sarno A
Ric Clin Lab; 1983; 13 Suppl 3():465-8. PubMed ID: 6324326
[TBL] [Abstract][Full Text] [Related]
8. [Effects of proxazole on patients with obliterating arteriopathy of the lower limbs].
Saponaro A; Russo R; Tomei F; Giordano M; Dragagna G; Barbato G
Clin Ter; 1979 Dec; 91(6):585-92. PubMed ID: 544162
[No Abstract] [Full Text] [Related]
9. [Role of the blood platelets in the atherosclerotic process and clinical use of a new drug, Suloctidil, with anti-aggregating activity].
Armani U; Piana A
Arch Maragliano Patol Clin; 1979; 35(2):57-62. PubMed ID: 233645
[No Abstract] [Full Text] [Related]
10. Effect of suloctidil on platelet function in patients with shortened platelet survival time.
Turpie AG; Gent M; deBoer AC; Giroux M; Kinch D; Butt R; Gunstensen J; Saerens E; Genton E
Thromb Res; 1984 Aug; 35(4):397-406. PubMed ID: 6091290
[TBL] [Abstract][Full Text] [Related]
11. [Short-term heparin therapy in obliterating arteriopathies of the lower limbs].
Arrigo F; Coglitore S; Giannetto M; Bramanti O; Barbera C; Consolo F
Boll Soc Ital Cardiol; 1977; 22(3):273-82. PubMed ID: 617274
[No Abstract] [Full Text] [Related]
12. [Chronic senile cerebrovascular insufficiency. Effects of suloctidil and pentoxifylline on erythrocyte deformability].
Pilla G; Ciaponi A; Migliavacca A; Bonora C
Ric Clin Lab; 1983; 13 Suppl 3():459-64. PubMed ID: 6324325
[TBL] [Abstract][Full Text] [Related]
13. Effect of suloctidil on tomographically quantitated platelet accumulation in Dacron aortic grafts.
Stratton JR; Ritchie JL
Am J Cardiol; 1986 Jul; 58(1):152-6. PubMed ID: 3014851
[TBL] [Abstract][Full Text] [Related]
14. Studies of suloctidil in experimental thrombosis in baboons.
Hanson SR; Harker LA
Thromb Haemost; 1985 Jun; 53(3):423-7. PubMed ID: 2996168
[TBL] [Abstract][Full Text] [Related]
15. [Suloctidil (sulocton) in the treatment of atherosclerotic neurasthenic syndromes].
Prusiński A; Kotwica S; Niewodniczy A; Split W
Wiad Lek; 1982 May; 35(3-4):201-5. PubMed ID: 6287740
[No Abstract] [Full Text] [Related]
16. [Platelet aggregation in obliterating arteriopathies of the lower limbs. Preliminary findings].
Rossi M; Evangelisti L; Giusti C; Santoro G; Pentimone F; Camici M
Minerva Cardioangiol; 1982 Jun; 30(6):329-33. PubMed ID: 7133421
[No Abstract] [Full Text] [Related]
17. [Behavior and meaning of beta-thromboglobulin in chronic obliterative arteriopathy of the lower extremities. Preliminary study].
Binaghi F; Valle E; Manconi E; Pitzus F
Cardiologia; 1982 Nov; 27(11):1043-9. PubMed ID: 6204655
[No Abstract] [Full Text] [Related]
18. [Comparative etiology of obliterating arteriopathy of the lower limbs and of coronary arteriopathy].
Schwartz D; Lellouch J; Anguera G; Richard JL; Beaumont JL
Rev Atheroscler; 1965; 7():Suppl 3:24-32. PubMed ID: 5885322
[No Abstract] [Full Text] [Related]
19. Inhibition of platelet function by ticlopidine in arteriosclerosis obliterans of the lower limbs.
Davì G; Pinto A; Francavilla G; Paterna S; Campisi D; Strano A
Thromb Res; 1985 Oct; 40(2):275-81. PubMed ID: 2933846
[No Abstract] [Full Text] [Related]
20. [Evaluation of the clotting system and fibrinolysis after 1-stage novocaine parasciatic blockade in patients with obliterating atherosclerosis of the lower limbs].
Kempf Z
Przegl Lek; 1970 Sep; 26(9):735-7. PubMed ID: 5472570
[No Abstract] [Full Text] [Related]
[Next] [New Search]
